+ 1 (418)-527-0388     [email protected]
Our ordering system is currently in maintenance.

About us

The company is based on values that are very dear to us, namely highly attentive customer care, quality products, as well as innovation, and on its collaboration with many key opinion leaders in the dentistry field.

Both a pioneer and a leader, Panthera Dental has successfully combined creativity, science and know-how to develop its proprietary innovative technology and is now able to offer next-generation products to the dental industry worldwide.

Our mission

Designing, developing, manufacturing and marketing high-level dental restoration solutions, mandibular advancement devices, and related products using superior quality materials and an advanced proprietary CAD/CAM process.

About us

The company is based on values that are very dear to us, namely highly attentive customer care, quality products, as well as innovation, and on its collaboration with many key opinion leaders in the dentistry field.

Both a pioneer and a leader, Panthera Dental has successfully combined creativity, science and know-how to develop its proprietary innovative technology and is now able to offer next-generation products to the dental industry worldwide.

Our mission


Designing, developing, manufacturing and marketing high-level dental restoration solutions, mandibular advancement devices, and related products using superior quality materials and an advanced proprietary CAD/CAM process.

  • MANAGEMENT

    Gabriel Robichaud

    President / Co-founder

    Gabriel Robichaud leads the strategic direction and the overall development of the company.

    He graduated from Laval University in Business Administration and from Cégep de Lévis-Lauzon in Industrial Robotics. He then followed additional training programs in management, including one in Project Management at École de technologie supérieure (ÉTS).

    Béatrice Robichaud

    VP Marketing & Customer Experience / Co-founder

    Béatrice Robichaud is responsible for new product launches, product introduction at the international level, and customer technical support.

    She is the co-founder of Panthera Dental, a lecturer, and a Specialist in High Technology CAD/CAM Dental Products. She graduated in Telecommunications at Collège radio télévision de Québec (CRTQ). During her career, she led several lectures in English and French in 10 different countries and trained over 400 dental specialists in the CAD/CAM dental field.

    David "Kim" Solomon

    Vice-President Sales, U.S.A.

    David "Kim" Solomon is responsible for sales, marketing, and brand development for Panthera Dental in the United States. He is a sales and marketing executive with expertise in business development, product launch, CAD/CAM digital technology, and clinical/restorative solutions. He is specialized in both direct and distributor sales channels with focus on B2B and B2C. Through the years, Kim has built sales and marketing teams for public and private dental companies in the clinical/restorative, medical device, and laboratory service industries.

    Kyle Steadman, CPA, CGA

    Chief Financial Officer

    Kyle Steadman is a seasoned manager with over 15 years of experience in financial management, controlling, planning and corporate development activities. He is responsible for Panthera Dental’s overall financial management, including the company’s financial reporting, long-range business planning, treasury and internal controls and he is an active participant in corporate development. Kyle has gained growing experience in international corporate activities working in both public and private Med-Tech companies on various projects including computer system migrations, internal control system set-up and surveillance, international taxation and change management..

    Don Murray

    Vice-President, Corporate Development

    Graduated from McGill University, Don Murray is a senior technology business development manager with 25 years of multinational B2B experience. He is in charge of Panthera Dental’s business relations and corporate development for all Panthera products. Don Murray has a successful track record in corporate-wide change management, international business development, sales channel management, product development & manufacturing ramp-up including after-sales service for complex products and systems. He is multilingual with field experience in the United-States, Europe, Brazil, Japan and China.

  • BOARD OF DIRECTORS

    Jean-Pierre Desmarais

    Chairman

    Jean-Pierre Desmarais is the CEO of Innovitech Inc., an innovation expert firm in the field of Medical Technologies and Aerospatiale.

    Jean-Pierre has more than 40 years’ experience in the medical device industry from large multinational to small startups and a vast expertise in Medical Technology from inception to commercialization; from early R&D, pre-clinical and clinical research, commercial approval globally; inclusive of USFDA, EU CE Australia, Japan; global reimbursement programs and early strategic commercialization globally.

    He served as President of Piramal Healthcare Bio-Orthopedics, a spin off from Montréal engineering school École Polytechnique, in the field of cartilage repair, that resulted into the technology acquisition in 2016 by Smith+Nephew, an orthopedic giant company. Prior to Piramal, Jean-Pierre worked at CryoCath Technologies as the Chief Scientific Officer in the field of cardiac electrophysiology. This Canadian technology startup from Montréal, founded in 1995 and acquired in 2008 by Medtronic USA for 400M$., treated more than 350,000 individuals around the world and had a profound healthcare and quality of life impact in the lives of people suffering from of Atrial Fibrillation.

    Jean-Pierre also served as Interim General Manager MDCC in 2016, a Medical Device Commercialization Center from the Federal Government National Centre of Excellence. Jean-Pierre holds a B.Sc. in Microbiology from Sherbrooke University, Canada and has served on several Boards of Medical Devices trade associations such as MEDEC Canada, MedTeQ as well as medical devices startup companies such as Hexoskin (connected health wearables), Biorthex (a spine company), Cardianove (an LVAD cardiology company), CyBiocare (a diabetes company) and BioSyntech (orthopedics) acquired by Piramal in 2010.

    Gabriel Robichaud

    Gabriel Robichaud is a senior executive with more than 15 years of experience in operations management for medtech companies with an emphasis on personalized medicine. He has been instrumental in the launch of several start-up companies that reached sustainable growth and great success. These success stories have been achieved through his fresh vision, leadership, and strong sense of innovation. Gabriel draws on a creative and strategic approach to solve issues and manage effectively. Since the beginning of his career, he has often played a leading role in product development and recruitment to build high-performing teams.

    Diane Robichaud

    Diane Robichaud is Laboratory Director at Panthera Dental and a member of the research and development team working on mandibular advancement devices for the treatment of snoring and obstructive sleep apnea. Having worked in the field of dentistry for more than 30 years, Diane is a member of the Ordre des techniciens et techniciennes dentaires du Québec and holds a laboratory management permit. She received two awards for the excellence of her work and co-founded a dental laboratory that she subsequently sold to dedicate herself to sleep problems at Panthera. Holder of a certificate in accounting sciences from Laval University, the daily management, administration and development of a SME brought her experience in different administration and management activity sectors. She is passionate about healthy sleep.

    Nicola Urbani

    Nicola Urbani has more than 15 years of experience in venture capital investments, primarily in life sciences and cleantech, with two different venture capital groups: GeneChem Management and CIC Capital Ventures. Dr. Urbani has served on numerous Boards and helped shape company strategies, C-level management teams and Board committees. Dr. Urbani has had an active involvement in the growth of several companies developing therapeutics through human clinical trials, and participated in numerous financing rounds with top tier International and Canadian venture capital funds. Prior to joining CIC Capital Ventures, Dr. Urbani was the VP Commercialization at the McGill-affiliated Jewish General Hospital in Montreal, where he was responsible for technology transfer and creating start-up companies. Dr. Urbani received his Ph. D in molecular genetics from McGill University and his MBA from Université du Québec à Montréal.

    Luc Marengère

    Dr. Marengère is a Managing Partner with TVM Capital Life Sciences. Luc has overseen the implementation of the Canadian operations and the North American investment strategy. Also, Luc co-manages the relationship with strategic partner Eli Lilly.

    Dr. Marengère has joined TVM LSV VII in 2011 and has more than 20 years of venture capital experience. Luc oversaw a number of investments on behalf of TVM LSV VII and is a Director on the Boards of Ixchelsis Ltd (UK); PRCL Pharma (Canada); Aurka Pharma (Canada); Panthera Dental Inc. (Canada); FAAH Pharma (Canada); Kaneq Biosciences (Canada), Acer Therapeutics (USA); TeserX Pharma (USA). Luc was a Director on the Board of Colucid Pharma (USA) sold to Eli Lilly in March 2017 for US$960M.

    Prior to joining TVM Capital, Luc was a Managing General Partner with VG Partners where he founded and ran the VG Advanced Life Sciences Fund (VG ALSF - CDN$230M). Luc was a Director on the Boards of Trillium Technologies Inc. (NASDAQ listed); Cytochroma Inc., (Sold to Opko for US$400M); Aegera Therapeutics Inc. (Sold to Pharmascience Ltd); Cita Neuropharma (sold to Vernalis Plc for US$85M) and lastly Argos Therapeutics Inc., (NASDAQ listed). Luc also invested in VisualSonics Inc. (sold to Sonosite for US$75M).

    Prior to joining VG Partners, Luc focused on making venture investments in the life science sector while with La Caisse De Dépôt's venture arm SOFINOV and MDS Capital Corp. Prior to his venture capital career, he conducted commercially-oriented research in the fields of immunology and oncology while at Amgen. Luc holds a Ph.D. from University of Toronto’s department of Medical Biophysics and Molecular Genetics.

  • SALES REPRESENTATIVES

    Canada


    Louis-Philippe Rochefort

    Regional Sales Director,
    Eastern Canada

    Andreas Klie

    Regional Sales Director,
    Ontario

    Kevan Vance

    Regional Sales Director,
    Western Canada

    Jean-François Brault

    Regional Sales Director,
    Montreal and Outaouais

    USA


    Bill Ballard

    Regional Sales Director,
    Plains Region

    Richard Dunn

    Regional Sales Director,
    Northeast Region of the US

    Anthony Pacheco

    Regional Sales Director,
    Great Lakes

    Jack Manno

    Educational Adviser
    Panthera Academy


    Kevin McAndrews

    Regional Sales Director – Southeast

    Stacey Kiel

    Regional Sales Director - Central - Dental Sleep Division

    Gabe Sayer

    Regional Sales Director, West Coast - Dental Sleep Division

    Mathew Lane

    Regional Sales Director – West Coast

    Europe


    Christophe Paulé

    Sales Director - Europe

NEED MORE INFORMATION?

Headquarters


2035 rue du Haut Bord
Québec, Québec
Canada, G1N 4R7
+ 1 (418) 527-0388

USA


1 Meadowlands Plaza, Suite 200
East Rutherford, NJ
USA 07073
+ 1 (855)-233-0388

France


20 rue de la Villette
Bureau 513, Immeuble Le Bonnel
69003 Lyon
+33 04 26 68 50 15

Media


Download media kit
Press Releases

  

Newsletter

+ 1 (418)-527-0388      [email protected]


Newsletter


Panthera Dental